Study of LED Phototherapy for Musculoligamentous Lesions

The purpose of this study is to determine whether LED phototherapy using combined red and near infrared light (approved: Ministry of Health of Russian Federation No. 29/06070997/1080-00, EUROCAT Certificate No. CP033321-IV) is effective in the treatment of musculoligamentous lesions in physiotherapy practice

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Tendinopathy Epicondylitis Fasciitis Muscle Spasm Muscular Diseases Musculoskeletal Diseases Nervous System Diseases Neurologic Manifestations Neuromuscular Manifestations Pathological Conditions, Signs and Symptoms Signs and Symptoms Spasm Sprains and Strains Tendon Injuries Wounds and Injuries

Age range

16 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

CAID, Hermano Miguel Foundation, Quito, Pichincha, Ecuador

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Clinical diagnosis of acute or chronic musculoligamentous lesion
Must be able to understand instructions and fill in auto administered questionnaires
Informed consent

Exclusion criteria

Use of oral corticosteroids or corticosteroid injections
Systemic diseases
General contraindications for phototherapy

Treatment and study plan

Red and near infrared LED phototherapy device

Device

Sponsors and collaborators

Lead sponsor

Hermano Miguel Foundation

Other

Registry information

Important dates

First posted: Oct 2, 2006
Registry last updated: Dec 8, 2008

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed